Prelude Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History

Prelude Capital Management’s Portfolio CLDI Stock Details CLDI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$322K	Sell
2022 Q1	$594K	Buy